Previous studies have shown that several forms of the glycoprotein ten
ascin are present in the embryonic extracellular matrix. These forms a
re the result of alternative splicing, which generates tenascin varian
ts with different numbers of fibronectin type III repeats. We have use
d degenerate primers and PCR to isolate a novel tenascin exon from an
avian genomic library. Genomic clones contained a sequence encoding a
fibronectin type III repeat that corresponds to repeat 'C' from the va
riable domain of human tenascin. To demonstrate that tenascin containi
ng repeat 'C' is actually synthesized by avian cells, a monospecific a
ntiserum was raised against a repeat 'C' fusion protein. This antiseru
m recognized a novel high-molecular-weight variant on immunoblots of t
enascin isolated from chicken embryo fibroblast-conditioned medium, an
d stained tendons on frozen sections of chicken embryos. A cDNA probe
specific for mRNA encoding repeat 'C' was used for in situ hybridizati
on, This probe hybridized in a subset of the embryonic tissues labelle
d with a universal tenascin probe, including tendons, ligaments and me
senchyme at sites of epithelial-mesenchymal interactions. Finally, we
provide evidence that additional fibronectin type ITC repeats, one cor
responding to a recently discovered human repeat as well as one entire
ly novel sequence, also exists in chicken tenascin mRNA. These data in
dicate that tenascin is present in the embryonic matrix in a multitude
of forms and that these forms have distinctive distributions that may
reflect more than one function for tenascin in development.